Form 4: Sight Sciences CFO Alison Bauerlein Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Alison Bauerlein, CFO of Sight Sciences, sold 19,397 shares of common stock on April 2, 2025, to cover tax liabilities related to vesting restricted stock units.
Summary
- On April 2, 2025, Alison Bauerlein, the Chief Financial Officer of Sight Sciences, Inc. (SGHT), sold 19,397 shares of the company's common stock.
- The sale was executed at a price of $2.309 per share.
- This transaction was conducted to cover the reporting person's tax liability associated with the vesting of restricted stock units.
- Following the transaction, Bauerlein directly owns 649,794 shares of Sight Sciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to an insider stock sale for tax purposes. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
Form 4 filings are a routine part of insider trading activity and are required by the SEC to provide transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, although it is a common practice for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/02/2025 | Date of stock sale transaction |
| 04/03/2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, Sight Sciences, SGHT, Alison Bauerlein, CFO, stock sale, tax liability, restricted stock units, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.